LimFlow is poised to help patients with severe peripheral artery disease
A French company is developing a therapy that will restore blood flow to the lower leg of patients who have virtually no circulation.
A French company is developing a therapy that will restore blood flow to the lower leg of patients who have virtually no circulation.
Approximately 6.5 million Americans are affected by advanced non-healing wounds each year.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.